Abraxane/Bevacizumab
Clinical trial NCT01821859 · TERMINATED
Trial details
- NCT number
- NCT01821859
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2011-11-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.